SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-22-015281
Filing Date
2022-10-25
Accepted
2022-10-25 08:30:15
Documents
14
Period of Report
2022-10-25
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmbr-20221025x8k.htm   iXBRL 8-K 35629
2 EX-99.1 tmbr-20221025xex99d1.htm EX-99.1 15808
  Complete submission text file 0001558370-22-015281.txt   182299

Data Files

Seq Description Document Type Size
3 EX-101.SCH tmbr-20221025.xsd EX-101.SCH 3729
4 EX-101.DEF tmbr-20221025_def.xml EX-101.DEF 2725
5 EX-101.LAB tmbr-20221025_lab.xml EX-101.LAB 17262
6 EX-101.PRE tmbr-20221025_pre.xml EX-101.PRE 10072
8 EXTRACTED XBRL INSTANCE DOCUMENT tmbr-20221025x8k_htm.xml XML 4908
Mailing Address 110 ALLEN ROAD, SUITE 401 BASKING RIDGE NJ 07920
Business Address 110 ALLEN ROAD, SUITE 401 BASKING RIDGE NJ 07920 914-205-3481
Timber Pharmaceuticals, Inc. (Filer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37411 | Film No.: 221327249
SIC: 2834 Pharmaceutical Preparations